BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6358608)

  • 1. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
    Checkik BE; Perets A; SenGupta S; Fernandes B
    J Natl Cancer Inst; 1983 Nov; 71(5):999-1010. PubMed ID: 6358608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
    Trotta PP; Tedde A; Ikehara S; Pahwa R; Good RA; Balis ME
    Cancer Res; 1981 Jun; 41(6):2189-96. PubMed ID: 6972248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
    J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
    Barton RW
    Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
    Holland MJ
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and identity of adenosine deaminase-positive cells in tissues of the young rat and calf.
    Chechik BE; Baumal R; Sengupta S
    Histochem J; 1983 Apr; 15(4):373-87. PubMed ID: 6190785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosine.
    Paine RM; Weston BJ; Clink HM; Kohn J; Neville AM; McGhee KG; Harrap KR
    Cancer Treat Rep; 1981; 65(3-4):259-66. PubMed ID: 6972254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunomorphologic study of adenosine deaminase distribution in human thymus tissue, normal lymphocytes, and hematopoietic cell lines.
    Chechik BE; Schrader WP; Minowada J
    J Immunol; 1981 Mar; 126(3):1003-7. PubMed ID: 7007497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
    Ratech H; Hirschhorn R; Thorbecke GJ
    Am J Pathol; 1985 Apr; 119(1):65-72. PubMed ID: 3872599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of deoxycoformycin-resistant cells with increased levels of adenosine deaminase.
    Hoffee PA; Hunt SW; Chiang J
    Somatic Cell Genet; 1982 Jul; 8(4):465-77. PubMed ID: 6981855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ; Buurman WA; van der Linden CJ
    J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
    Helland S; Ueland PM
    Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
    Earle MF; Glazer RI
    Mol Pharmacol; 1983 Jan; 23(1):165-70. PubMed ID: 6602939
    [No Abstract]   [Full Text] [Related]  

  • 14. 2'-deoxycoformycin. A new anticancer agent.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    Cancer Clin Trials; 1981; 4(2):209-13. PubMed ID: 7018725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of 2'-deoxycoformycin on mitogen-induced lymphoproliferation in the neonatal period.
    Romo A; Lorente F; Salazar V
    Allergol Immunopathol (Madr); 1988; 16(4):243-7. PubMed ID: 3265855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 2'-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat.
    Geiger JD; Lewis JL; MacIntyre CJ; Nagy JI
    Neuropharmacology; 1987 Sep; 26(9):1383-7. PubMed ID: 3499581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase gene amplification in deoxycoformycin-resistant mammalian cells.
    Rowland P; Pfeilsticker J; Hoffee PA
    Arch Biochem Biophys; 1985 Jun; 239(2):396-403. PubMed ID: 3873908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of adenosine deaminase activity in cultured murine cytotoxic T lymphocytes.
    Minkowski MD; Castellazzi M; Buttin G
    J Immunol; 1984 Jul; 133(1):52-8. PubMed ID: 6609994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the relationship between adenosine deaminase and immune function.
    Burridge PW; Paetkau V; Henderson JF
    J Immunol; 1977 Aug; 119(2):675-8. PubMed ID: 301901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.